Energy Drinks and Cardiac Complications: A Case Report of ST-Elevation Myocardial Infarction in a Young Man

Augusto Esposito1*, Ilenia Foffa1,2, Simone Sorbo1, Cecilia Vecoli1,2, Maria Giovanna Colombo1, mberto Paradossi1 and Sergio Berti1,2.

¹Ospedale del Cuore, Fondazione Toscana "G. Monasterio," Massa, Italy.
²Institute of Clinical Physiology, CNR, Massa, Italy.

*Corresponding author

*Dr. Augusto Esposito, Via Aurelia Sud 54100, Massa, Italy. Email: augustoesposito1990@gmail.com

Abstract

We report the clinical presentation of a 22-year-old male admitted at our facility with an acute ST-segment elevation myocardial infarction despite having no family history or other apparent risk factors beyond an excessive energy drink consumption. The patient reported consuming between seven to nine cans of energy drink per day in the previous weeks. Coronagraphic study showed total occlusion of the anterior descending artery and subocclusion of diagonal branch with wide distribution territory. Follow-up at one month showed suspected left ventricular apical thrombotic apposition. The patient started warfarin therapy for 3 months with complete resolution of the apical thrombosis. He is currently on six-monthly follow-up with good response to the prescribed therapy. This report shows a potential link between these beverages and myocardial ischemia, especially in young people. This evidence aspires to raise awareness about the energy drink-associated risk to prevent adverse health effects and to sensitise the general population to the prudent consumption of such drinks.

Key words: Cardiovascular events; Energy drinks; Acute myocardial infarction in young; Arrhythmia; apical thrombosis

Introduction

Energy drink (ED) consumption has become increasingly popular among adolescents and young adults in recent years (De Sanctis, 2017; Khouja, 2022) and is often used to improve weight loss, athletic performance, energy level, concentration, and decrease the aftereffects of alcohol. The Food and Drug Administration (FDA) defines energy drinks (EDs) as “a class of products in liquid form that typically contains caffeine, with or without other added ingredients.” They typically contain large amounts of caffeine, added sugars, other additives, and legal stimulants such as guarana, taurine, and L-carnitine. The safety of EDs remains debatable, as there are several cases where they have produced adverse events in patients. In the literature, the excessive consumption of energy drinks has been associated with cardiovascular events such as tachycardia, myocardial infarction, and death (Finnegan, 2003; Berger, 2009; Fletcher, 2017; Shah, 2019). The European Cardiac Arrhythmia Society would like to draw attention to the possible cardiovascular complications that may occur with these beverages and to emphasize the prevention measures to be taken mainly in the young population (Lévy, 2019). Here, we present the case of a 22-year-old male who was admitted with ST-Elevation Myocardial Infarction (STEMI) following the consumption of energy drink.

Case presentation

A 22-year-old Caucasian man alerted the emergency services to chest pain, nausea and vomiting about an hour after finishing a football match. On arrival at the emergency department, the patient appeared highly agitated and sweating, with initial signs of haemodynamic instability (blood pressure [BP]: 100/70 mm Hg, heart rate [PR]: 90 beats/minute, respiratory rate [RR]: 26 breaths/minute, temperature: 36.6°C, oxygen saturation: 99%, body mass index [BMI]: 25.7 kg/m2). The man was referred to our tertiary centre to undergo coronary angiography. The patient reported consuming approximately 20 cans of energy drink over the previous three days. Interesting, a complete anamnesis revealed an average daily intake of seven to nine cans of energy drink containing caffeine during the last weeks. His medical history excluded alcohol use and smoking habits. There was no family history of ischaemic heart disease, sudden cardiac death and unexplained syncope. In addition, the patient denied illicit drug use. In summary, he had no apparent cardiovascular risk factors.

On admission to the haemodynamic room, the electrocardiogram (ECG) showed sinus rhythm with marked ST elevation in the anterolateral leads (V2-V5, I, aVL) and reciprocal changes in the inferior leads (III and aVF) (Figure 1). A transthoracic echocardiogram (ECHO) demonstrated akinesia of the apex in toto and moderate left ventricular dysfunction without valvular defects and/or pericardial effusion.  Coronagraphic study showed total occlusion of the anterior descending artery and subocclusion of diagonal branch with wide distribution territory (Figure 2A). During the primary percutaneous revascularization procedure, multiple aspirations were performed followed by several dilations on both affected vessels and finally placement of a medicated stent on the anterior descending artery (Figure 2B). Subsequent drug therapy involved dual antiplatelet therapy with concomitant 24-hour infusion of Tirofiban ev. During the procedure, 5 episodes of ventricular fibrillation (VF) were treated by DC shock and infusion of cordarone and magnesium sulphate ev. After 3 days the angiographic result is optimised with OCT and post dilatation of stent.

Figure 1: Electrocardiogram displaying sinus rhythm with marked ST elevation in the anterolateral leads (V2-V5, I, aVL) and reciprocal changes in the inferior leads (III and aVF)

Genetic screenings for thrombophilia resulted negative. As regard laboratory data, we found only a slight hypercholesterolaemia and glomerular filtration rate (GFR) values lower than normal for age in relation to a nephrosclerosis from urinary infections occurring in childhood.  In addition, study for patent foramen ovale (PFO) paradoxical embolism, echo-abdomen and chest CT scan to exclude neoplastic embolism and toxicological tests were all negative. The post-procedural course was normal with discharge of the patient after 7 days of hospitalisation. Follow-up at one month showed suspected left ventricular apical thrombotic apposition, in the context of severe left ventricular dilatation and apical akinesia in toto. Subsequent follow-up with cardiac MRI confirmed the suspicion (Figure 3). The patient started warfarin therapy for 3 months with complete resolution of the apical thrombosis. He is currently on six-monthly follow-up with good response to the prescribed therapy.

Discussion

In this case report, we presented the case of a healthy young man with no apparent risk factors for cardiovascular disease with a final diagnosis of ST elevation myocardial infarction (STEMI). We suspected the cardiac event experienced by this individual was secondary to his high intake of an energy drink in the days and weeks preceding. This report aspires to raise awareness of the potentially lethal effects of energy drinks and to sensitise the general population to the prudent consumption of such drinks because of there is growing evidence of a causative role of caffeinated energy drinks on human health, particularly on the cardiovascular and neurovegetative systems (Costantino, 2023). There are several potential mechanisms that, individually or in combination, could support this hypothesis (Berger, 2009; Kaur, 2022) and, given the popularity and increasing use of energy drinks, it is certainly an association that merits further investigation. The cardiovascular effects of these drinks seem to involve platelet aggregation and endothelial dysfunction, resulting in a state of relative hypercoagulability and increased likelihood of thrombosis (Worthley, 2010; Pommerening, 2015). Furthermore, cardiovascular effects include supraventricular and ventricular tachyarrhythmias (Holmgren, 2004). These EDs contain ingredients such as caffeine, taurine, sugar and glucuronolactone and differ substantially in both caffeine content and concentration. It is well known that toxic effects of caffeine include vomiting, abdominal pain and central nervous system (CNS) symptoms, including agitation, altered state of consciousness, rigidity and convulsions.

Figure 2: Coronarographic study pre (2A) and post percutaneous revascularization procedure (2B)

Figure 3: Follow-up cardiac magnetic resonance (CMR) one month after the acute event. Late gadolinium enhancement (LGE) images: A) 4-chamber view and B) 2-chamber view show LGE with a subendocardial-transmural pattern (ischemic pattern) in the mid-distal anterior wall and the apex, with a small apical thrombus (red arrow). T2-weighted STIR images: C) 4-chamber view and D) 2-chamber view show hyperintensity in the apex, suggestive of myocardial edema due to the recent ischemic event.

In particular, caffeine has a direct chronotropic and positive inotropic effects on the heart and at high doses, it induces vascular smooth muscle contraction, increases peripheral vascular resistance and blood pressure slightly (Cappelletti, 2018). It is claimed that taurine and gluconolactone are the main components responsible for the effects attributed to Red Bull. Specifically, taurine, a derivative of the amino acid cysteine, has recently been shown to protect against ischemia and heart failure and is found in abundance in cardiac and skeletal muscles where regulate potassium, calcium and sodium levels thus, affecting the excitability of the myocardium [Lake, 1987; Satoh, 1998]. In a recent review, Costantino et al. reported nine cases of cardiac arrest, three of which were fatal with an aetiology attributed to the inherent neurostimulant properties of these beverages (Costantino, 2023). Furthermore, it was found that the risk of cardiovascular outcomes is increased in individuals with pre-existing structural or hereditary heart disease and that adverse cardiovascular effects have also been found with the use of other substances, such as alcohol. Also, experimental studies on animal model reported acute and chronic adverse health effects related to use of EDs consistent with observations in humans affecting various organs or systems (Sali, 2018; Ellermann, 2022; Demirel, 2023). However, although the pathophysiology between energy drink intake and myocardial ischaemia has not been fully elucidated, the preponderance of data suggests that these drinks are not harmless. There is still a substantial amount of unknown information on EDs despite their consumption behaviour remains very high, especially among teenagers, and the absence of regulatory oversight has resulted in aggressive marketing of energy drinks. This uncertainty leads us to conduct further research and, it is prudent to recommend limited consumption of such drinks. Nadeem et al, in a recent review, recommend in fact that individuals avoid frequent energy drink consumption (5-7 energy drinks/week) and avoid co-consumption with alcohol since the document coingestion of energy drinks with alcohol significantly increased the risk of adverse events (Needem, 2021). Moreover, in the future, children, adolescents and young people should be better informed about the ED-associated risk to prevent adverse health effects. So, there is a pressing need for a deeper understanding of novel risk factors that contribute to Acute Myocardial Infarction in young patients and the screening of emerging novel markers is important in preventing young patients with Acute Myocardial Infarction particularly where conventional risk factors are absent (Ranjan, 2024). The Abuse of energy drinks could be a new emerging novel risk factors associated with young STEMI which need intervention to reduce morbidity and mortality.

Funding: “The authors declare that no funds, grants, or other support were received during the preparation of this manuscript.”

Competing Interests: “The authors have no relevant financial or non-financial interests to disclose.”

Author Contributions: “All authors contributed to the study conception and design.  Clinical, Coronagraphic and percutaneous revascularization procedures were performed by Augusto Esposito, Simone Sorbo, Umberto Paradossi. Genetic screening for thrombophilia was performed by Maria Giovanna Colombo. The first draft of the manuscript was written by Ilenia Foffa, Augusto Esposito and Cecilia Vecoli and all authors commented on previous versions of the manuscript. Sergio Berti critically reviewed the manuscript as supervisor. All authors read and approved the final manuscript.”

Ethics approval: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Consent to participate: “Informed consent was obtained from all individual participants included in the study.”

Consent to publish: “The authors affirm that human research participants provided informed consent for publication of the images in Figure(s) 1,2,3.”

References

  1. De Sanctis V, Soliman N, Soliman AT, Elsedfy H, Di Maio S, El Kholy M, Fiscina B. Caffeinated energy drink consumption among adolescents and potential health consequences associated with their use: a significant public health hazard. Acta Biomed. 2017;88:222-231. doi: 10.23750/abm.v88i2.6664.
  2. Khouja C, Kneale D, Brunton G, Raine G, Stansfield C, Sowden A, Sutcliffe K, Thomas J. Consumption and effects of caffeinated energy drinks in young people: an overview of systematic reviews and secondary analysis of UK data to inform policy. BMJ Open. 2022;12:e047746. doi: 10.1136/bmjopen-2020-047746.
  3. Fletcher EA, Lacey CS, Aaron M, Kolasa M, Occiano A, Shah SA. Randomized Controlled Trial of High-Volume Energy Drink Versus Caffeine Consumption on ECG and Hemodynamic Parameters. J Am Heart Assoc. 2017;6:e004448. doi: 10.1161/JAHA.116.004448.
  4. Berger AJ, Alford K. Cardiac arrest in a young man following excess consumption of caffeinated "energy drinks". Med J Aust. 2009;190:41-3. doi: 10.5694/j.1326-5377.2009.tb02263.x.
  5. Shah SA, Szeto AH, Farewell R, Shek A, Fan D, Quach KN, Bhattacharyya M, Elmiari J, Chan W, O'Dell K, Nguyen N, McGaughey TJ, Nasir JM, Kaul S. Impact of High Volume Energy Drink Consumption on Electrocardiographic and Blood Pressure Parameters: A Randomized Trial. J Am Heart Assoc. 2019;8:e011318. doi: 10.1161/JAHA.118.011318.
  6. Costantino A, Maiese A, Lazzari J, Casula C, Turillazzi E, Frati P, Fineschi V. The Dark Side of Energy Drinks: A Comprehensive Review of Their Impact on the Human Body. Nutrients. 2023;15:3922. doi: 10.3390/nu15183922
  7. Kaur A, Yousuf H, Ramgobin-Marshall D, Jain R, Jain R. Energy drink consumption: a rising public health issue. Rev Cardiovasc Med. 2022;23:83. doi: 10.31083/j.rcm2303083. PMID: 35345250.
  8. Worthley MI, Prabhu A, De Sciscio P, Schultz C, Sanders P, Willoughby SR. Detrimental effects of energy drink consumption on platelet and endothelial function. Am J Med. 2010;123:184-7. doi: 10.1016/j.amjmed.2009.09.013.
  9. Pommerening MJ, Cardenas JC, Radwan ZA, Wade CE, Holcomb JB, Cotton BA. Hypercoagulability after energy drink consumption. J Surg Res. 2015;199:635-40. doi: 10.1016/j.jss.2015.06.027.
  10. Holmgren P, Nordén-Pettersson L, Ahlner J. Caffeine fatalities--four case reports. Forensic Sci Int. 2004;139:71-3. doi: 10.1016/j.forsciint.2003.09.019.
  11. Cappelletti S, Piacentino D, Fineschi V, Frati P, Cipolloni L, Aromatario M. Caffeine-Related Deaths: Manner of Deaths and Categories at Risk. Nutrients. 2018;10:611. doi: 10.3390/nu10050611.
  12. Lake N., de Roode M., Nattel S. Effects of taurine depletion on rat cardiac electrophysiology: In vivo and in vitro studies. Life Sci. 1987;40:1017–1026. doi: 10.1016/0024-3205(87)90322-5.
  13. Satoh H, Sperelakis N. Review of some actions of taurine on ion channels of cardiac muscle cells and others. Gen Pharmacol. 1998;30:451-63. doi: 10.1016/s0306-3623(97)00309-1.
  14. Salih, Nadia Abdulkarim; Abdul-Sadaand, Israa Hameed1; Abdulrahman, Nawzad Rasheed1. Histopathological Effect of Energy Drinks (Red Bull) on Brain, Liver, Kidney, and Heart in Rabbits. Medical Journal of Babylon 15:p 16-20, 2018. | DOI: 10.4103/MJBL.MJBL_5_18
  15. Ellermann C., Hakenes T., Wolfes J., Wegner F.K., Willy K., Leitz P., Rath B., Eckardt L., Frommeyer G. Cardiovascular risk of energy drinks: Caffeine and taurine facilitate ventricular arrhythmias in a sensitive whole-heart model. J. Cardiovasc. Electrophysiol. 2022;33:1290–1297. doi: 10.1111/jce.15458.
  16. Demirel A., Başgöze S., Çakıllı K., Aydın U., Şentürk G.E., Diker V.O., Ertürk M. Histopathological Changes in the Myocardium Caused by Energy Drinks and Alcohol in the Mid-term and Their Effects on Skeletal Muscle Following Ischemia-reperfusion in a Rat Model. Anatol. J. Cardiol. 2023;27:12–18. doi: 10.14744/AnatolJCardiol.2022.2003.
  17. Nadeem IM, Shanmugaraj A, Sakha S, Horner NS, Ayeni OR, Khan M. Energy Drinks and Their Adverse Health Effects: A Systematic Review and Meta-analysis. Sports Health. 2021;13:265-277. doi: 10.1177/1941738120949181. Epub 2020 Nov 19. PMID: 33211984; PMCID: PMC8083152.
  18. Ranjan A, Agarwal R, Mudgal SK, Bhattacharya S, Kumar B. Young hearts at risk: Unveiling novel factors in myocardial infarction susceptibility and prevention. J Family Med Prim Care. 2024;13:1200-1205. doi: 10.4103/jfmpc.jfmpc_1639_23.
TOP